The challenges of COVID-19 for community pharmacists and opportunities for the future.
John C HaydenRebecca ParkinPublished in: Irish journal of psychological medicine (2020)
Pharmacists, like psychiatrists, have modified their practices amidst COVID-19 in order to guarantee care and support to their patients. Designated an essential frontline service, community pharmacists are facing a spectrum of challenges to surmount to ensure patient care continues. These include assisting in the prevention of infection, managing supply chains, preventing stockpiling and provision of evidence-based medical information. However, disasters like COVID-19 disproportionately affect poor and vulnerable populations, and patients with mental health conditions may be among the hardest hit. Pharmacist-level, system-level and regulatory responses have sought to minimise this impact, although there is likely to be a lasting impression on the profession, both good and bad. This article reviews the pandemic-related challenges and responses by pharmacists, as well as forming recommendation for areas of professional support and role expansion, particularly in the case of mental health.
Keyphrases
- mental health
- coronavirus disease
- sars cov
- healthcare
- end stage renal disease
- mental illness
- respiratory syndrome coronavirus
- palliative care
- general practice
- newly diagnosed
- ejection fraction
- chronic kidney disease
- primary care
- peritoneal dialysis
- transcription factor
- quality improvement
- randomized controlled trial
- current status
- drug induced